Bayer

Glowing puzzle piece fitting into puzzle
Biotech

Vividion secures clinical-stage WRN inhibitor from Roche

Bayer’s Vividion Therapeutics secured the global rights from its partner Roche to the only covalent WRN inhibitor to have made it into the clinic.
James Waldron Jun 4, 2025 9:21am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS oncology head swings to Syndax—Chutes & Ladders

May 16, 2025 8:30am
cellos without players

Bayer boosts precision oncology efforts with multiyear AI deal

Apr 23, 2025 12:55pm
water over rocks

Bayer moves allogeneic cell therapy into ph. 3 Parkinson's trial

Jan 13, 2025 2:30am
Graphic image of an arrow nailing the bullseye of a target

Bayer’s hot flash drug hits goal in phase 3 breast cancer trial

Jan 9, 2025 7:40am
scoop of pink ice cream

Sanofi scoops up China rights to Cytokinetics' heart disease med

Dec 20, 2024 11:07am